US Stock MarketDetailed Quotes
SBFMW SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)
- 0.120
- 0.0000.00%
Trading Aug 16 14:13 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low40Volume0.110Open0.120Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.35052wk High0.00P/B0Float Cap0.03652wk Low--Dividend TTM0Shs Float7.600Historical High--Div YieldTTM0.00%Amplitude0.036Historical Low0.000Avg Price1Lot Size
SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 67.30%9.3M | 54.09%7.54M | 454.42%24.09M | 94.94%7.68M | 4,385.93%5.96M | 3,599.67%5.56M | 3,890.42%4.89M | 1,802.41%4.35M | 4,528.68%3.94M | 163.63%132.81K |
| Operating revenue | 67.30%9.3M | 54.09%7.54M | 454.42%24.09M | 94.94%7.68M | 4,385.93%5.96M | 3,599.67%5.56M | 3,890.42%4.89M | 1,802.41%4.35M | 4,528.68%3.94M | 163.63%132.81K |
| Cost of revenue | 92.53%6.95M | 69.17%5.19M | 494.69%15.75M | 108.77%5.11M | 5,931.06%3.97M | 4,731.24%3.61M | 5,023.12%3.07M | 2,148.18%2.65M | 3,895.36%2.45M | 237.24%65.78K |
| Gross profit | 20.66%2.36M | 28.78%2.35M | 391.53%8.34M | 72.22%2.57M | 2,869.42%1.99M | 2,482.18%1.95M | 2,811.02%1.83M | 1,434.03%1.7M | 6,157.61%1.49M | 117.12%67.03K |
| Operating expense | 22.18%3.62M | 1.31%3.7M | 26.55%13.12M | -42.47%3.76M | 55.17%2.77M | 284.57%2.97M | 184.34%3.66M | 306.57%10.37M | 2,051.20%6.53M | 238.63%1.79M |
| Selling and administrative expenses | 21.29%2.99M | 7.63%3.36M | 14.26%10.83M | -56.02%2.82M | 71.76%2.44M | 241.06%2.47M | 239.24%3.13M | 408.01%9.48M | 2,966.82%6.41M | 371.58%1.42M |
| -Selling and marketing expense | 92.47%256.33K | 54.83%198.05K | 27.01%734.25K | 30.14%231.26K | 11.13%241.9K | 51.89%133.18K | 34.59%127.91K | --578.09K | --177.7K | --217.67K |
| -General and administrative expense | 17.23%2.74M | 5.62%3.17M | 13.43%10.1M | -58.48%2.59M | 82.72%2.2M | 267.16%2.33M | 262.78%3M | 377.03%8.9M | 2,881.83%6.23M | 299.38%1.2M |
| Research and development costs | 18.36%436.24K | -48.71%222.03K | 128.59%1.86M | 1,854.67%816.33K | -34.34%238.01K | 702.22%368.57K | 19.71%432.93K | 20.77%811.86K | -54.21%41.76K | 62.95%362.5K |
| Depreciation amortization depletion | 45.86%50.87K | 22.78%42.62K | 492.72%149.15K | 123.16%42.35K | 4,616.10%37.21K | 1,425.01%34.88K | 1,016.08%34.71K | 97.50%25.16K | 496.01%18.98K | -75.21%789 |
| -Depreciation and amortization | 45.86%50.87K | 22.78%42.62K | 492.72%149.15K | 123.16%42.35K | 4,616.10%37.21K | 1,425.01%34.88K | 1,016.08%34.71K | 97.50%25.16K | 496.01%18.98K | -75.21%789 |
| Other taxes | 50.86%145.81K | 19.12%75.9K | 424.57%289.74K | 39.02%76.78K | --52.59K | --96.65K | --63.72K | --55.23K | --55.23K | --0 |
| Operating profit | -25.09%-1.27M | 26.16%-1.35M | 44.83%-4.79M | 76.43%-1.19M | 54.63%-779.47K | -45.72%-1.01M | -49.50%-1.83M | -255.47%-8.67M | -1,701.26%-5.04M | -246.19%-1.72M |
| Net non-operating interest income expense | -28.02%143.75K | -45.08%94.91K | 40.78%674.67K | 85.04%157.5K | -35.27%168.9K | 36.75%199.72K | 1,443.64%172.81K | 245.75%479.24K | 332.38%85.12K | 656.97%260.94K |
| Non-operating interest income | -29.08%144K | -32.63%144.09K | 56.56%811.97K | 68.01%187.61K | -20.51%207.43K | 39.03%203.05K | 7,129,266.67%213.88K | --518.65K | --111.67K | --260.94K |
| Non-operating interest expense | -92.64%245 | 19.73%49.18K | 248.39%137.31K | 13.43%30.11K | 1,926,250.00%38.53K | --3.33K | 219.30%41.08K | -88.01%39.41K | -27.53%26.55K | -100.00%2 |
| Other net income (expense) | 109,883.52%286.54K | -38,546.67%-5.77K | 100.00%-245 | 100.00%-39 | 60.00%40 | -102.40%-261 | 266.67%15 | -89.46%-18.32M | -1,963.70%-18.33M | 100.00%25 |
| Gain on sale of security | 109,883.52%286.54K | -38,546.67%-5.77K | 48.53%-245 | 92.51%-39 | 60.00%40 | -1,000.00%-261 | 266.67%15 | -1,052.00%-476 | -2,842.11%-521 | -32.43%25 |
| Special income (charges) | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -89.46%-18.32M | -1,963.69%-18.33M | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --18.33M | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.11%-10.85K | --0 | ---- |
| Income before tax | -2.89%-837.99K | 23.83%-1.26M | 84.49%-4.11M | 95.58%-1.03M | 58.10%-610.53K | -51.14%-814.43K | -33.97%-1.66M | -113.17%-26.51M | -3,589.50%-23.28M | 63.93%-1.46M |
| Income tax | -492.00%-343.69K | -51.69%22.35K | 69.38%395.17K | -5.59%220.27K | 40.95K | 87.68K | 46.27K | 233.3K | 233.3K | 0 |
| Net income | 45.21%-494.3K | 24.59%-1.28M | 83.15%-4.51M | 94.68%-1.25M | 55.29%-651.48K | -67.41%-902.11K | -37.71%-1.7M | -115.05%-26.74M | -3,624.47%-23.51M | 63.93%-1.46M |
| Net income continuous Operations | 45.21%-494.3K | 24.59%-1.28M | 83.15%-4.51M | 94.68%-1.25M | 55.29%-651.48K | -67.41%-902.11K | -37.71%-1.7M | -115.05%-26.74M | -3,624.47%-23.51M | 63.93%-1.46M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 45.21%-494.3K | 24.59%-1.28M | 83.15%-4.51M | 94.68%-1.25M | 55.29%-651.48K | -67.41%-902.11K | -37.71%-1.7M | -115.05%-26.74M | -3,624.47%-23.51M | 63.93%-1.46M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 45.21%-494.3K | 24.59%-1.28M | 83.15%-4.51M | 94.68%-1.25M | 55.29%-651.48K | -67.41%-902.11K | -37.71%-1.7M | -115.05%-26.74M | -3,624.47%-23.51M | 63.93%-1.46M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg